Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate the efficacy and safety of bevacizumab plus carboplatin and paclitaxel
in patients with advanced or recurrent non-small-cell lung cancer.
Title:
Journal of clinical oncology : official journal of the American Society of Clinical
Oncology
Publisher:
American Society of Clinical Oncology (ASCO)
ISSN: 0732-183X
ISSN
(Print):
0732-183X
Publication date
(Electronic):
Jun 01 2004
Volume: 22
Issue: 11
Affiliations
[1
]
Division of Hematology & Oncology, Vanderbilt University Medical School, 777 Preston
Research Bldg, Nashville, TN, USA. david.johnson@vanderbilt.edu